SYSTEMIC LUPUS ERTHEMATOSUS
Clinical trials for SYSTEMIC LUPUS ERTHEMATOSUS explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC LUPUS ERTHEMATOSUS trials appear
Sign up with your email to follow new studies for SYSTEMIC LUPUS ERTHEMATOSUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can we give COVID and flu shots together? new study for vulnerable patients
⭐️ VACCINE ⭐️ Recruiting nowThis study looks at the best way to give COVID-19 booster and flu shots to people with weakened immune systems (like those with rheumatoid arthritis, organ transplants, or HIV). It will compare getting both vaccines on the same day versus one month apart, and also test if getting…
Matched conditions: SYSTEMIC LUPUS ERTHEMATOSUS
Phase: PHASE2 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: ⭐️ VACCINE ⭐️
Last updated May 08, 2026 12:01 UTC
-
Cord blood stem cells could tame lupus – first human trial underway
Disease control Recruiting nowThis early-stage study tests a single injection of stem cells from donated umbilical cords in 10 adults with active lupus. The goal is to see if the treatment is safe and can reduce disease activity and improve kidney function. Participants continue their usual medications and ar…
Matched conditions: SYSTEMIC LUPUS ERTHEMATOSUS
Phase: PHASE1 • Sponsor: LiveKidney.Bio • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Engineered immune cells aim to tame childhood autoimmune diseases
Disease control Recruiting nowThis early-phase study tests a new treatment using specially engineered natural killer (NK) cells to target and calm overactive B cells in children with autoimmune diseases like lupus and IgA nephropathy. The goal is to see if this therapy is safe and can help control the disease…
Matched conditions: SYSTEMIC LUPUS ERTHEMATOSUS
Phase: EARLY_PHASE1 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New lupus drug GR1803 enters human trials
Disease control Recruiting nowThis study tests a new medicine called GR1803 for people with systemic lupus erythematosus (SLE), an autoimmune disease where the body attacks itself. The trial will check if the drug is safe and if it helps control lupus symptoms. About 44 adults with active lupus who are alread…
Matched conditions: SYSTEMIC LUPUS ERTHEMATOSUS
Phase: PHASE1, PHASE2 • Sponsor: Genrix (Shanghai) Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 05, 2026 11:54 UTC
-
Fatigue mystery: scientists seek to classify exhaustion
Knowledge-focused Recruiting nowThis study aims to understand the different types of fatigue people experience, especially those with conditions like cancer, lupus, and chronic fatigue syndrome. Researchers will compare fatigued and non-fatigued adults using interviews, questionnaires, physical tests, and optio…
Matched conditions: SYSTEMIC LUPUS ERTHEMATOSUS
Sponsor: National Center for Complementary and Integrative Health (NCCIH) • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC